The genetic basis of variation in human cognitive abilities is poorly understood. RIMS1 encodes a synapse active-zone protein with important roles in maintenance of normal synaptic function: mice lacking this protein have greatly reduced learning ability and memory function. We used an established paradigm examining structural and functional effects of mutations in genes expressed in the eye and the brain to study a kindred with an inherited retinal dystrophy due to RIMS1 mutation.
Introduction
A genetic contribution to variation in human intelligence is well-established, but the identities of the genes responsible remain elusive. Many mutations are associated with impaired cognition 1 : no definite genetic causes of enhanced cognition are established 2 -there are no known cognition-enhancing "gain-of-function" mutations in genes otherwise associated with cognitive impairment. Therapeutic possibilities deriving from discovery of any such genes or variants are potentially important: cognitive decline reduces quality of life 3 , and low intelligence test scores are associated with increased morbidity and shorter life-span. 4 Accelerated evolution of genes subserving neurodevelopment figures in molecular explanations of advance of the human nervous system: many of the identified genes regulate brain size and behaviour, some encoding critical synaptic proteins. 5 To identify genes influencing human brain development and function, including cognitive function, we employ a paradigm evaluating cerebral structure and function in individuals with known mutations in genes co-expressed in the lineagesharing eye and brain, ascertained by their obvious ocular phenotype, but in whom a neurological phenotype was not fully appreciated. Using this paradigm, we have demonstrated roles for the genes PAX6, PITX2, SOX2 and OTX2 in human brain development, cognitive function and memory. [6] [7] [8] [9] [10] [11] We now report on the functional and structural effects of mutation in the eyeand brain-expressed gene RIMS1, through the study of individuals from a family already reported to have retinal dystrophy caused by RIMS1 mutation. 12, 13 To our knowledge, this is the only family thus far reported with such a mutation: the eye phenotype is homogeneous in the family, and has been documented in detail. 13 The orthologous murine Rim1α encodes a synaptic active-zone protein necessary for preserving normal probability of synaptic neurotransmitter release and for long-term presynaptic potentiation. 14, 15 Rim1α is also expressed in retinal ribbon synapses.
Results

Cognitive function is enhanced in individuals with RIMS1 mutation
The pedigree is illustrated in Figure 1 . Eight (of nine total) affected and seven (of nine total) unaffected adults were assessed. The verbal intelligence quotient (VIQ) is a composite measure generated from a range of tests. VIQ was pro-rated from the Wechsler Adult Intelligence Scale (Revised; WAIS-R) Vocabulary, Digit Span and Similarities subtests. 19 VIQs in affected individuals (Table 1) were all above average with quotients ranging from the 75 th (high average ability) to the 99 th centile (superior ability). Centile levels for subjects II:2 and II:6 are probably underestimates, as normative data are available up to 75 years only. Some pro-rated VIQ scores eg 150 in subject III:1, reflect a ceiling effect. On measures of memory and executive skills, performance levels were more variable with some scores falling below average. Normative data available for these measures were based on smaller sample sizes than for VIQ and, with the exception of semantic fluency, were not available for older age bands. The identification of RIMS1 (and its mutation) as causal in this kindred might usually be undertaken using linkage analysis, both for the previously reported retinal phenotype (maximum LOD score 3.61 at theta = 0) and for the phenotype being considered here, verbal IQ. For verbal IQ, fewer informative members were tested: using a "high" IQ phenotype, classified as greater than 1 standard deviation (15 verbal IQ points) above the mean, to calculate linkage gives a maximum LOD value of 1.92 at a recombination fraction (theta) of 0.2, which is highly indicative of linkage. This analysis, however, imposes a somewhat arbitrary interpretation on the verbal IQ phenotype, and does not allow account to be taken of the other cognitive information available.
Fortunately, the process of Mendelian inheritance allows a further robust test of the causality of the Arg844His mutation to be performed, avoiding the usual problems of confounding from other variables that might aggregate in a familial fashion but be unlinked to the mutation. To test the relevance of the mutation, affected and unaffected first-degree sibs in each generation (II:2, II:6, II:8 vs II:4; III:5 vs III:7; IV:3 vs IV:4, IV:5) underwent identical cognitive testing ( Table 1 ).The mean age of affected members (53.8 years) was higher than unaffected members (41.1 years), acting conservatively against any superior cognitive performance in the affected group, given the known effect of age. 20 We tested the significance of the association between affected status and every measured cognitive phenotype following a randomisation approach that accounts for kindred structure.
21 RIMS1 genotypes are randomised across the pedigree, following Mendelian inheritance, while keeping the phenotype values of each individual fixed. The null hypothesis therefore allows for the possibility of familial effects on phenotype that are unlinked to RIMS1, and any significant departure from the null hypothesis can only be ascribed to an effect linked to RIMS1. The eleven measured phenotypes were: vocabulary (subcomponent of verbal IQ), digit span (subcomponent of verbal IQ), similarities (subcomponent of verbal IQ), phonemic fluency, cognitive estimates, immediate story recall, delayed story recall, immediate verbal learning, delayed verbal learning, semantic fluency and Hayling Test.
The perfect observed association between affected status and the RIMS1 mutation allowed us to infer a dominant Mendelian disease model and also to infer the genotypes of all founders and marry-ins. We simulated genotypes, and thence the affected status, of all individuals in the pedigree based on Mendelian inheritance from the known founders, and for each normalised phenotype we calculated the difference in means between affected and non-affected (keeping phenotype values fixed among individuals). To address multiple testing issues, we generated a single score for the overall difference between the affected and non-affected groups. We first normalised all phenotypes to a common variance scale, dividing by the standard deviations estimated from a disease-control group of fifteen visually-impaired individuals with mutation in PAX6, 7 so all phenotypes had equal weight. We then used the Euclidean distance of the eleven difference-in-means values. To control for possible ascertainment bias, we further conditioned on the observed number of affected and non-affected in the pedigree by rejecting any pedigrees from the Monte Carlo process that did not match this. We carried out 10,000 simulations under these conditions. The single score for the overall difference in all mean phenotype values between affected and non-affected was significant (P=0.006). For individual phenotypes, all except those for immediate story recall, delayed story recall and semantic fluency had P values less than 5%: vocabulary (P=0.014), digit span (P=0.020), similarities (P=0.039), phonemic fluency (P=0.050), cognitive estimates (P=0.012), immediate story recall (P=0.112), delayed story recall (P=0.087), immediate verbal learning (P=0.048), delayed verbal learning (P=0.042), semantic fluency (P=0.220) and Hayling Test (P=0.010). As expected, given that the three subphenotypes of verbal IQ were all significant, when we separately tested verbal IQ itself this was also significant (P=0.014).
We determined to what extent the coincidence of these associations is due to the natural correlations among these phenotypes. Table 2 presents the correlation coefficients of the eleven phenotypes, plus verbal IQ, in the disease control sample of fifteen individuals with PAX6 mutation. 7 Given that the three sub-phenotypes of verbal IQ were all significant, when we separately tested verbal IQ itself this was also significant (P=0.014): whilst this particular result reflects a part-whole correlation, it is of note that the eleven cognitive phenotypes did not all naturally correlate with each other, as assessed in the disease control group. 7 Phonemic fluency, verbal learning and semantic fluency were highly correlated with verbal IQ, and it is unclear whether the significant results observed in some of these variables were due simply to correlation with verbal IQ. However, the phenotypes of cognitive estimates and Hayling Test were poorly correlated with verbal IQ, the other variables, and each other, possibly suggesting that multiple facets of mental processes were being affected independently by the mutation. There was no history or genetic evidence for inbreeding (number of markers scored = 16, heterozygous average for 14 members of kindred = 11.6 (72%); equivalent scores for 5 "married-ins" = 11.4 (71%); data from ref 22, omitting IV:4-7).
To address the specific, but unlikely 23 , possibility that visual impairment might enhance function in other domains, we compared identical measures from the disease-control cohort of fifteen individuals (mean age 36 years, range 17-54 years; eight females) all of whom had congenitally symptomatic PAX6 mutations. 7 The PAX6 subjects had earlier onset of visual symptoms and more severe central visual impairment at the time of cognitive testing than the RIMS1 subjects (Supplementary Table 1 ). The mean VIQ of the PAX6 subjects was 103. The PAX6 subjects as a group do not differ from the RIMS1 unaffected individuals: cognitive measures for both groups fall within the normal ranges (Table 3) . Despite their more severe and earlieronset visual impairment, the PAX6 affected individuals performed significantly less well than the RIMS1 affected individuals (VIQ, Mann-Whitney P<0.0005). In addition, in three of eight affected RIMS1 individuals, visual acuity was normal (6/6) or near normal (6/9) at the time of cognitive assessment. In seven affected members of the kindred, high-resolution brain MRI was obtained. In two, a mother (II:2) and son (III:1), brain abnormalities were apparent on inspection (Fig. 2a,b) . Cortical grey matter was preserved around widened CSF spaces: these changes would be compatible with a bilateral parasagittal polymicrogyric malformation.
RIMS1 genetic variation in other cone-rod dystrophy patients and a population cohort
We sequenced the mutation-containing RIMS1 exon 13 in a panel of 50 unrelated individuals with autosomal dominant cone-rod dystrophy but did not detect any mutations. Common variation in RIMS1 (uncorrelated with the rare Arg844His mutation), did not influence cognitive function in LBC1921, either for genotype or haplotype (see Supplementary material, Tables 2 and 3 ). To determine if mutation in RIMS1 might account for the upper extreme of performance on cognitive measures, the entire RIMS1 gene was sequenced in the top scoring 5% of the LBC (24 individuals). Only one, previously unreported, SNP was found, in residue 592, exon 9: it was synonymous, conserving a glutamic acid residue in an unremarkable region of the gene.
RIMS1 brain expression in human fetal and adult brain
In situ hybridisation with an anti-sense RIMS1 probe in fetal stage 1 human embryos revealed RIMS1 expression in the outer plexiform layer of the developing retina, but not in the optic nerve, as expected (Figure 3a ,b,c,f). Cerebral expression was seen in the ventricular zone, developing cortical plate, thalami and hippocampal anlage (Fig. 3c,d,e,g ). Telencephalic RIMS1 hybridisation signal was detectable from 57 days post-conception onwards, but not before. In adult human hippocampi from patients who had undergone therapeutic resective surgery for refractory temporal lobe epilepsy due to hippocampal sclerosis, RIMS1 expression was observed at least in the granule cell layer and CA1 (Figure 3h ): in the absence of other suitable adult brain material, expression elsewhere cannot be excluded.
RIMS1 evolution
The value of the ratio of non-synonymous (K A ) to synonymous (K S ) nucleotide substitution is a measure of selection pressure on a gene: overwhelmingly, nonsynonymous alterations are deleterious, and subject to negative selection. Rarely, nonsynonymous changes improve protein function and are subject to positive selection, with an elevated K A /K S . To determine whether RIMS1 has been subject to positive selection, we estimated RIMS1 K A /K S for humans in comparison to chimpanzee and macaque, considered against rate change in a rodent divergence (rat-mouse) following Dorus et al. 5 We were unable to demonstrate accelerated evolution of RIMS1 in the primate lineage (see Supplementary material).
Discussion
Few individual genetic factors underlying the heritability of human intelligence are known. 2 Mutations in many genes, inherited in Mendelian fashion, are associated with reduced intelligence 1 , often associated with other problems. Notably, recent variation in two such genes (MCPH1 and ASPM) has been shown to be subject to strong positive selection indicating ongoing adaptive evolution of the human brain 24, 25 and emphasising the importance of population genetic analyses of genes mutations in which affect human cognition. Quantitative trait analyses in populations with learning disabilities also suggest genes with Mendelian effects when mutated are candidates to broadly influence normal variation in learning abilities in the general population. 26 To our knowledge, no human genetic mutations have yet been identified that enhance cognitive function.
We show that a mutation in RIMS1 is associated, in the only reported kindred with any RIMS1 mutation, with significantly enhanced cognitive function in at least the verbal (likely to be related to general ability, g) and executive domains. RIMS1 is an excellent candidate gene to influence cognitive function. Rim1α protein regulates synaptic-vesicle fusion, interacts with several other active-zone molecules, including alpha-liprins, Munc 13-1, CAST, SNAP-25, synaptotagmin and 14-3-3, generating a protein scaffold in the presynaptic terminal. 27 Rim1α greatly enhances neurotransmitter exocytosis in a Rab3-dependent manner. 28 Absence of Rim1α protein leads to severe impairment of learning and memory. 17 Could the RIMS1 mutation be a chance finding, unrelated to the eye or cognitive phenotype? The intrafamilial distribution of cognitive measures argues that the detected mutation is most likely causative, especially as it segregates with both the eye phenotype (which becomes clinically symptomatic) and the cognitive enhancement. Co-mingling in each outbred generation of mutation-carrying and wildtype sibs each with respective enhanced or normal cognitive phenotype and the respective, co-segregating impaired or normal visual phenotype, renders extremely unlikely the possibility of an intrafamilial founder effect unrelated to the RIMS1 mutation, as supported quantitatively by our modelling, beyond linkage analysis alone.
We have not demonstrated a molecular basis by which the R844H substitution in RIMS1 could enhance cognition. The possibility remains that there is a mutation (or mutations) in another gene (or genes) in the region between markers D6S430 and D6S1625 (ref. 12) which is (or are) responsible for both the retinal and cognitive phenotypes, or the retinal and cognitive phenotypes separately. Within this region there are at least 17 other genes. Two of these, IMPG1 and MYO6, were considered good candidates for the eye phenotype alongside RIMS1 on the basis of function and pattern of expression and were screened by Johnson et al. 12 BAI3 was subsequently screened (Cottrill and Hunt, unpublished data): no mutations were found in any of these other three genes. Yet other genes, such as KCNQ5, where there is no evidence for retinal expression, have not been examined, and would not be candidates for the eye phenotype, but could be for the brain phenotype. However, we consider it more likely on the basis of the available evidence, including biological plausibility 14, 15, 17 , that the R844H mutation in RIMS1 explains both the eye phenotype and the cognitive phenotype, with a lower lod score for the cognitive phenotype as this is more genetically complex and the mutation probably less penetrant.
One interpretation of our findings is that the RIMS1 mutation in this kindred alone (i.e. with this genetic background and environmental setting) is permissive of a gain of verbal cognitive abilities in response to impaired visual function, rather than directly causative. This is inherently unlikely, especially in this kindred, as with increasing age higher cognitive abilities are usually associated with better, rather than defective, sensory processing. 23 In the RIMS1 kindred, development of visual symptoms occurs later than the age at which values of cognitive measures (eg NART, VIQ) are set -for example, subject III:2 did not develop symptomatic retinal dystrophy until aged 42, but had VIQ 146 at age 49. In addition, three mutationcarriers in the kindred had normal visual function at the time of cognitive assessment. Additionally, visual impairment due to PAX6 mutation in unrelated subjects with earlier and more severe loss of central vision, was not associated with any gain in VIQ. The data suggest, therefore, that the observed genetic change is a gain-offunction mutation leading to increased performance in specific cognitive domains in affected humans, irrespective of other genetic background and unrelated to visual impairment. The RIMS1 mutation studied may affect other cognitive domains -the paradigm we applied is biased to tests requiring only auditory presentation and verbal response and verbal, not visual, processing and was used for subjects we suspected of having cognitive impairment, not cognitive enhancement. Thus only a limited cognitive assessment was undertaken, in line with our previous reports. We note that, undoubtedly, other genes must also contribute to cognitive scores in this kindred.
The RIMS1 gene shows extensive organ-specific alternative mRNA splicing. 12 Thus, although the mutation lies in the protein C 2 A domain, and is shared by the eye and brain isoforms, nevertheless the ocular neurophysiology in the kindred 13 need not reflect mutant brain RIMS1 protein function. Lack of homogeneity within a kindred for the functional consequences of gene mutation has previously been noted. 6 Our qualitative structural findings also implicate RIMS1 as a candidate gene for bilateral parasagittal polymicrogyria. The brain malformation is not a prerequisite for the cognitive phenotype in this kindred, and indeed when cognition is altered in patients with polymicrogyria, it is usually impaired.
RIMS1 is a plausible candidate not only because of data from animal studies discussed earlier, but also in terms of the pattern of expression in humans. Thus, human RIMS1 mRNA is detectable from an early age not only in retinal, but also in cerebral, anlagen (Figure 3) , and in adult human hippocampus (Figure 3h ). RIMS1 protein is more abundant in phylogenetically newer brain regions than in older regions. 28 However, we were not able to demonstrate accelerated evolution of RIMS1 in the primate lineage, nor were genes encoding RIMS1-interacting molecules primate-fast outliers in a previous analysis. 5 The population genetic data suggest RIMS1 may not have a major role in normal variation of the studied cognitive measures in a Western European population. Any evolutionary advantage of this particular mutation could be counterbalanced by the concomitant severe visual phenotype, albeit of late onset. Whilst population genetic studies can provide useful, or even conclusive, evidence that a gene and its encoded protein have a biological function, negative population genetic studies do not exclude such a role. The genetics of Parkinson's disease illustrate this well: rare, early-onset, Mendelian cases may be caused by mutation in PINK1, 29 but common variation in PINK1 does not influence the risk of common, sporadic Parkinson's disease. 30 Further work is clearly required before a role for RIMS1 in human cognition can be formally accepted. However, even if the observed RIMS1 mutation turns out to be a private mutation enhancing cognition in affected members of this kindred only, the observation remains important because as the first such mutation identified in humans, it raises the possibility that genetic mutations may lead to increased, as well as reduced, cognitive function in man. The kindred studied. Filled symbols represent affected individuals, unfilled symbols unaffected individuals. Note that the kindred is an extension of that presented by Johnson et al. 12 and Kelsell et al. 22 , reordered by age of generation II (and thus does not appear identical to previous presentations). In situ hybridisation for RIMS1 mRNA in human embryonic eye (a) from Carnegie stage 21. The purple labelling represents expression of RIMS1, found as expected in the developing retinal pigment epithelium, shown at higher power in (b). (a) and (b) are sagittal images. In (c), a tilted coronal section through the developing human head at fetal stage 1 shows expression in the developing cortical anlage (d, higher power), hippocampal anlagen (e, arrows), and retina, but not in the optic nerve (on) (f). Expression is present in both the subventricular zone and cortical plate (g, arrowheads). In adult human hippocampus (h), from a patient with temporal lobe epilepsy, expression (purple labelling) is seen in small cells in the (neuron-depleted) dentate granule cell (GCL-) layer and CA1 sector (CA1-), in comparison to the sections labelled with the sense-probe as control (GCL+, CA1+).
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The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd to permit this article (if accepted) to be published in Journal of Medical Genetics and any other BMJPGL products and sublicences such use and exploit all subsidiary rights, as set out in our licence (http://jmg.bmjjournals.com/ifora/licence.pdf ). The subject had to produce as many words beginning with the letter S (phonemic fluency) and as many animal names (semantic fluency) both in a minute. Performance on fluency tests, particularly for the phonemic category (letter "s"), is a sensitive indicator of frontal lobe functioning. 31 2) The Hayling Test is a response suppression task. The subject has to complete two series of 15 sentences each missing the last word. In the first section a sensible completion is required and in the second a nonsensical completion. The test yields two measures of mental processing speed and an error score for the second series. Performance on this measure has been shown to involve frontal brain regions in healthy individuals 32 and to be adversely affected by frontal lobe pathology. 33 3) Cognitive estimates. This is a semantic reasoning task that requires the subject to provide a reasonable estimation to ten questions that have no exact answer, based on their available semantic knowledge. The questions are of the format 'How fast do race horses gallop?'. Penalties are awarded for inaccurate responses and the higher the score the poorer the reasoning demonstrated. This test has been shown to be sensitive to frontal lobe pathology. 19, 34 Memory. 1) Verbal Recall. This was assessed using the Story Recall subtest from the Adult Memory and Information Processing Battery. 35 The subject is read a short story and then has to recall as many details as possible immediately following presentation and again following a delay of 30 minutes. Performance measures used were the immediate recall score and the % retained score (delayed recall/immediate recall x 100). 2) Verbal Learning. The List Learning test from the AMIPB was employed. The subject is presented with a list of 15 words on five occasions and following each presentation has to recall as many of the words as possible. A second list of words is then presented and following one attempt at recall is required to recall as many words from the first list (delayed recall). The total number of words remembered in the learning phase (verbal learning trails) and in the delayed recall condition (verbal learning delay) were recorded.
MRI in kindred
Coronal T1-weighted images were acquired at 1.5T: acquisition parameters were TE= 4.2, TI= 450, TR= 15, NEX= 1, flip angle= 20, acquisition matrix 256 x 128, field of view 24cm, producing 124 contiguous slices, voxel dimension 0.9375mm x 0.9375mm x 1.5mm. Data were reformatted in multiple planes to allow careful examination of regions of interest. Additionally T2 and FastFLAIR sequences were obtained (T2 and PD sequence: TE1= 30, TE2= 120, TR= 2000, NEX= 1, acquisition matrix 256 x 128, field of view 24x18cm, slice thickness 5mm contiguous; FastFLAIR sequence TE1= 152, TE2= 2200, TR= 10002, NEX= 1, acquisition matrix 256 x 128, field of view 24cm, slice thickness 5mm contiguous).
Cognitive testing in the LBC1921 cohort
Mini-Mental State Examination (MMSE):
MMSE 36 was as used as a screen for dementia. The maximum score is 30. A score of less than 24 was used as an indicator of possible dementia.
Moray House Test (MHT):
This general mental ability test was previously described in detail. 18, 37 It mainly assesses verbal reasoning skills. Subjects took this test at the age of 11 and again at about age 79. Raven's Standard Progressive Matrices: Non-verbal reasoning was examined at age 79 using Raven's Standard Progressive Matrices. 38 Verbal fluency: Prefrontal executive function was examined at age 79 using the Verbal Fluency test. Subjects named as many words as possible in one minute for each of the letters C, F, L. 39, 40 Logical Memory: Verbal declarative memory was measured at age 79 using the Logical Memory test, which is a sub-test from Wechsler Memory Scale-Revised. 41 National Adult Reading Test (NART): NART was used at age 79 to assess prior cognitive ability. [42] [43] [44] g factor: A g factor, as a measure of general intelligence, was created by principal component analysis of the age 79 MHT, Raven's Standard Progressive Matrices, Verbal Fluency and Logical Memory scores. A single component accounted for 53.5% of the total variance.
Genotypic analysis in LBC1921 cohort
Genotyping of the tagging SNPs was carried out by TaqMan fluorescence based allelic discrimination, with primers designed using the Applied Biosystems (ABI) Assay by Design tool (Applied Biosystems, Foster City, CA). Polymerase chain reactions were carried out according to the standard ABI protocol for 5µl reaction volume on 384-well plates. SDS version 2.1 software (Applied Biosystems, Foster City, CA) was used for analysis. Primer sequences are available on request. Statistical analysis Multiple regression analyses were implemented in STATISTICA (StatSoft Inc, Tulsa, USA), with the respective cognitive measure as the dependent variable, and genotype scores as the independent predictors. Genotypes were scored using an unrestricted model allowing arbitrary effects of the genotypes at each locus. Regression analyses were performed both with and without including sex as an independent variable. Haplotype analyses were implemented using the haplo.stats software 45 , in the R console. Those individuals with data missing from more than two loci or present at less than two loci in the section were excluded from the haplotype analysis. Table 2 ), including both sex and genotype as predictors (n=469). There were no sex-by-genotype interactions, and none of the individual SNPs was associated with any of the cognitive measures. Sex was a significant predictor of score for Raven's matrices (P=0.0005), and g (P=0.03; P values uncorrected for multiple testing). Additionally, the haplotypes generated by the tagging SNPs from each section showed no association with any of the cognitive measures (Supplementary Table 3 ).
Generation of RIMS1 riboprobes and in situ hybridisation.
The cDNA sequence (nucleotides 590-995 numbering from the start codon) was amplified using the polymerase chain reaction from human brain cDNA (Clontech) using KOD DNA polymerase (Novagen). This was A-tailed and then inserted into the vector pGEM-T Easy (Promega). The construct was then sequenced using vector primers to check on the orientation of the insert. Antisense and sense probes were generated by in vitro transcription using T7 and SP6 RNA polymerase under standard procedures. Digoxigenin-dUTP was incorporated into riboprobes during in vitro transcription by using the DIG RNA labelling mix (Roche) according to the manufacturer's instructions. In situ hybridization was performed as reported in Lai et al. (7) 16 (2) 12 (5) 3 (1) Squirrel Macaque Chimpanzee Human Monkey Figure. Sequence analysis using the squirrel monkey as an outlying reference allows the identification of the origin of sequence changes between species (nonsynonymous changes in red). Of a total 77 variants, only three of them are specific to the human lineage (two synonymous changes and one nonsynonymous). The chimpanzee has the most species-specific nonsynonymous changes (5) , and the human-chimpanzee common ancestor has four. Due to limitations in the sequencing of squirrel monkey exons, 37 variants were unable to be assigned (seven of which are nonsynonymous changes, the majority of which (22) are located in exon 7, an exon that does not lie in a functional domain). Scores shown are the P-values for the global score statistic calculated for the overall haplotype effect for each gene section (labelled by dbSNP rs number) for each cognitive measure. P values are uncorrected for multiple testing. 
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